Idarucizumab for Dabigatran Reversal | Journal Scan

Study Questions:

What is the safety, tolerability, and efficacy of increasing doses of idarucizumab, a monoclonal antibody fragment that binds dabigatran, for the reversal of dabigatran’s anticoagulant effect?